Use of telemedicine in patients with heart failure

Česká verzia

Authors: Marie Lazárová ^1,2; Antonín Hlavinka ³; Patrik Šulc ¹; Jozef Dodulík ¹; Jan Václavík ^1,2
Authors place of work: Interní a kardiologická klinika, Fakultní nemocnice Ostrava ¹; Lékařská fakulta Ostravské univerzity, Ostrava ²; Filozofická fakulta Univerzity Palackého Olomouc ³
Published in the journal: Vnitř Lék 2022; 68(3): 154-158
Category: Main Topic

Summary

Chronic heart failure (HF), like any chronic disease, is a medical and socioeconomic burden. The number of patients with HF is increasing and our effort is to apply the most effective way of care in practice, preferably together with using telemedicine. Early diagnosis, therapy establishment and reduction of rehospitalizations play the key role in HF management. For patients for whom we add telemedicine (telephone consultation, physiological data transfer, data transfer from implantable devices, teleconsultation) and especially if we are able to provide the background of a well-functioning telemedicine center that is able to respond promptly to the data, we can recognize and respond to the deterioration in health status in a timely manner. Telemedicine has benefit in all aspects of care mentioned above, but mostly in the reduction of re-hospitalizations, which is related to the reduction of morbidity and mortality. Telemedicine in HF is also cost-effective.

Keywords:

morbidity – Telemedicine – mortality – chronic heart failure – telemonitoring – information and communication technology – teleconsultation – re‑hospitalization

Zdroje

1. McDonagh TA, Metra M, Adamo M et al. 2021 ESC Guidelines for the diagnosis andtreatment of acute and chronic heart failure. European Heart Journal (2021) 00, 1_128.

2. Táborský M, Skála T, Lazárová M et al. Trends in the treatment and survival of heart failure patients: a nationwide population‑based study in the Czech Republic. ESC Heart Failure. 2021;8:3800-3808.

3. Jaarsma T, Strömberg A, De Geest S et al. Heart failure management programmes in Europe. Eur J Cardiovasc Nurs. 2006 Sep;5(3):197-205.

4. Juillière, Jourdain P, Suty‑Selton C et al. Therapeutic patient education and all‑cause mortality in patiens with chronic heart failure: a propensity analysis. Int J of Cardiol. 2013 Sep 20;168(1):388-95.

5. Jhund PS, Macintyre K, Simpson CR et al. Long‑term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119:515-523.

6. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee‑for‑service program. N Engl J Med. 2009;360:1418-1428.

7. Cleland JG, Louis AA, Rigby AS et al. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: theTrans‑European Network‑Home‑Care Management System (TEN‑HMS) study. J Am Coll Cardiol. 2005 May 17;45(10):1654-1664.

8. Sousa C, Leite S, Lagido R et al. Telemonitoring in heart failure: A state‑of‑the‑art review. Rev Port Cardiol. 2014;33:229-239.

9. Andrès E, Talha S, Zulfigar AA et al. Current Research and New Perspectives of Telemedicine in Chronic Heart Failure: Narrative Review and Points of Interest for the Clinician. J. Clin. Med. 2018;7:544.

10. Inglis SC, Clark RA, McAlister FA et al. Which components of heart failure programmes are effective? A systematic review and meta‑analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: abridged Cochrane review. Eur J Heart Fail. 2011;13:1028-1240.

11. Inglis SC, Clark RA, McAlister FA et al. Structured telephone support or telemonitoring programmes. Cochrane Database Syst. Rev. 2010, 8, CD007228.

12. Anker SD. Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet. 2011;378:731-739.

13. Vaid A et al. Using Deep‑Learning Algorithms to Simultaneously Identify Right and Left Ventricular Dysfunction From the Electrocardiogram, Journal of the American College of Cardiology: Cardiovascular Imaging. 2021, DOI: 10.1016/j.jcmg.2021. 08. 004.

14. Koehler F, Koehler K, Deckwart O et al. Efficacy of telemedical interventional management in patients with heart failure (TIM‑HF2): A randomised, controlled, parallel‑group, unmasked trial. Lancet. 2018;392:1047-1057.

15. Lazárová M, Roubík L. Telemedicína u pacientů se srdečním selháním. Novinky v kardiologii. Praha: Mladá fronta; 2016. ISBN 9788020439840.

16. Achelrod D. Policy expectations and reality of telemedicine – A critical analysis of health care outcomes, costs and acceptance for congestive heart failure. J. Telemed. Telecare. 2014;20:192- 200.

17. Hindricks G, Taborsky M, Glikson M et al. Implant‑based multiparameter telemonitoring of patients with heart failure (IN‑TIME): a randomised controlled trial. Lancet. 2014; 384:583-590.

18. Abraham WT, Adamson PB, Bourge RC. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011 Feb 19;377(9766):658-66.

19. Abraham WT, Stevenson LW, Bourge RC et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow‑up results from the CHAMPION randomized trail. Lancet. 2016;387:453-461.

20. Lindenfeld J, Zile MR, Desai AS et al. Haemodynamic – guided management of heart failure (GUIDE‑HF), a randomized control trial. Lancet. 2021;398:991-1001.

21. Tersalvi G, Winterton D, Cioffi GM et al. Telemedicine in Heart Failure During COVID-19: A Step into the Future. Front. Cardiovasc. Med. 7:612818.

22. Kraai IH, Luttik ML, de Jong RM, Jaarsma T, Hillege HL. Heart failure patients monitored with telemedicine: Patient satisfaction, a review of the literature. J. Card. Fail. 2011; 17:684-690.